Imagine opening an email from your regional public health authority – or perhaps you don’t have to imagine at all. Many of us with school-aged children in Ontario have received one recently, a stark reminder of how fragile our sense of safety can feel when public trust in preventive care begins to waver. “Dear Parent/Guardian, …
Continue reading “What Happens When Healthcare Communications Break Down?”
Chronic insomnia affects millions of people, and it’s far more than just a frustrating night or two without sleep. For those who experience it, insomnia becomes a relentless cycle: the desperation to sleep intensifies anxiety, which makes sleep even harder to achieve. This is exactly what happened to my adult son during a particularly stressful …
In our last article, we discussed how “Healthy Aging” is emerging as a new, targeted therapeutic area. Among the most surprising candidates showing promise in this field are glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – medications originally developed to target diabetes. Research into GLP-1 RAs has an interesting history that started back in the early …
Continue reading “Could GLP-1 Receptor Agonists Become the First True “Longevity-Enhancing” Drugs?”
The life science industry has never moved faster, and the pace is only accelerating. Pipelines in oncology, rare disease, and cell and gene therapy are advancing with unprecedented velocity. Regulatory timelines are tightening, and the volume of new data is overwhelming traditional workflows. For medical communications agencies, this isn’t just about “keeping up.” It’s about …
Continue reading “Beyond Deadlines: The Growing Demands on MedComms”